Xilio Therapeutics, Inc.
NASDAQ:XLO
0.7559 (USD) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 55.291 | 44.704 | 120.385 | 198.053 | 19.238 | 48.845 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 55.291 | 44.704 | 120.385 | 198.053 | 19.238 | 48.845 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.943 | 3.423 | 8.222 | 8.928 | 1.352 | 2.259 |
| Total Current Assets
| 60.234 | 48.127 | 124.496 | 202.517 | 20.59 | 51.104 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 9.059 | 11.201 | 12.84 | 13.597 | 13.676 | 9.873 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | -5.092 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 1.562 | 1.553 | 1.551 | 0.194 |
| Tax Assets
| 0 | 0 | 0 | 3.539 | 0 | 0 |
| Other Non-Current Assets
| 1.782 | 1.598 | 0.267 | 1.946 | 0.5 | 1.551 |
| Total Non-Current Assets
| 10.841 | 12.799 | 14.669 | 15.543 | 15.727 | 11.618 |
| Total Assets
| 71.075 | 60.926 | 139.165 | 218.06 | 36.317 | 62.722 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 2.574 | 1.05 | 3.125 | 3.144 | 5.444 | 2.518 |
| Short Term Debt
| 1.188 | 3.315 | 7.585 | 0.801 | 2.897 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 13.518 | 0 | 0 | 8.751 | 13.732 | 0 |
| Other Current Liabilities
| 9.981 | 11.592 | 10.409 | 8.833 | 13.814 | 2.689 |
| Total Current Liabilities
| 27.261 | 15.957 | 21.119 | 12.778 | 22.155 | 5.207 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 6.954 | 8.142 | 12.354 | 19.735 | 18.32 | 18.631 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | -3.539 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 3.539 | 0 | 0 |
| Other Non-Current Liabilities
| 19.262 | 0 | 0.045 | 0.118 | 79.129 | 68.407 |
| Total Non-Current Liabilities
| 26.216 | 8.142 | 12.399 | 19.853 | 97.449 | 87.038 |
| Total Liabilities
| 53.477 | 24.099 | 33.518 | 32.631 | 119.604 | 92.245 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 218.06 | 78.002 | 68.033 |
| Common Stock
| 0.005 | 0.003 | 0.003 | 0.003 | 0.001 | 0 |
| Retained Earnings
| -383.753 | -325.512 | -249.108 | -160.886 | -85.086 | -29.867 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | -218.06 | -78.003 | 0 |
| Other Total Stockholders Equity
| 401.346 | 362.336 | 354.752 | 346.312 | 79.802 | -67.689 |
| Total Shareholders Equity
| 17.598 | 36.827 | 105.647 | 185.429 | -83.287 | -29.523 |
| Total Equity
| 17.598 | 36.827 | 105.647 | 185.429 | -83.287 | -29.523 |
| Total Liabilities & Shareholders Equity
| 71.075 | 60.926 | 139.165 | 218.06 | 36.317 | 62.722 |